This project develops a low-cost, paper-based diagnostic platform for rapid Dna extraction and detection of antimicrobial resistance genes to enable early sepsis diagnosis in decentralized settings. Using dipstick-based extraction and a colorimetric MARVE assay, it delivers results within 45 minutes, supporting WHO’s ASSURED guidelines and improving frontline antibiotic decision-making.
Accessibility Controls